Advertisement
Advertisement

NCEL

N

NewcelX Ltd. Ordinary Shares

2.77
USD
+0.10
+3.75%
Dec 18, 12:53 UTC -5
Closed
exchange

After-Market

2.71

-0.06
-2.02%

NewcelX Ltd. Ordinary Shares Profile

About

NewcelX is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. NewcelX, formerly known as NLS Pharmaceutics Ltd., is based in NESS ZIONA, Israel.

Info & Links

CEO

Alexander Zwyer

Headquarters

THE CIRCLE 6
ZURICH, V8 8058, SWITZERLAND

Sector

Medical

Auditor

Marcum llp

Share holders

--

Employees

3

NewcelX Ltd. Ordinary Shares Statistics

Valuation Measures

Market Capitalization2

12.37M

Enterprise Value

9.30M

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.38

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

0.00%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

0.00

Net Income Available to Common(ttm)

0.00

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.12

52-Week Change

--

S&P 500 52-Week Change

15.47%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

3.81M

% Held by Insiders

16.40%

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

3.07M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement